Overall Survival Benefit and Long‐Term Safety of Romiplostim in Persistent Chemotherapy‐Induced Thrombocytopenia

Andrew B. Song, Gerald A. Soff
American Journal of Hematology · Wiley · 2026-11-06 · DOI: 10.1002/ajh.70510

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles